Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N J James

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 1, 1996
The mechanism of inhibition of factor III (thromboplastin) activity by apolipoprotein B-100. Protein-protein interactionsC Ettelaie, N J James, B Wilbourn, et al.
Biochimica Et Biophysica Acta|April 21, 1997
Alterations in the structure of apolipoprotein B-100 determine the behaviour of LDL towards thromboplastinC Ettelaie, P I Haris, N J James, et al.
The Biochemical Journal|July 11, 1998
Identification of a domain in apolipoprotein B-100 that inhibits the procoagulant activity of tissue factorC Ettelaie, N J James, J M Adam, et al.
FEBS Letters|July 14, 1998
Modification of tissue factor by peroxynitrite influences its procoagulant activityJ M Adam, C Ettelaie, K M Naseem, et al.
FEBS Letters|December 22, 1999
The role of the C-terminal domain in the inhibitory functions of tissue factor pathway inhibitorC Ettelaie, J M Adam, N J James, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 1, 1996
The mechanism of inhibition of factor III (thromboplastin) activity by apolipoprotein B-100. Protein-protein interactionsC Ettelaie, N J James, B Wilbourn, et al.
Biochimica Et Biophysica Acta|April 21, 1997
Alterations in the structure of apolipoprotein B-100 determine the behaviour of LDL towards thromboplastinC Ettelaie, P I Haris, N J James, et al.
The Biochemical Journal|July 11, 1998
Identification of a domain in apolipoprotein B-100 that inhibits the procoagulant activity of tissue factorC Ettelaie, N J James, J M Adam, et al.
FEBS Letters|July 14, 1998
Modification of tissue factor by peroxynitrite influences its procoagulant activityJ M Adam, C Ettelaie, K M Naseem, et al.
FEBS Letters|December 22, 1999
The role of the C-terminal domain in the inhibitory functions of tissue factor pathway inhibitorC Ettelaie, J M Adam, N J James, et al.
Pageof 2